Redwood Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.36M	Buy	+10,826	New	+$1.36M	0.14%	204
2024 Q2	–	Sell	-4,652	Closed	-$642K	–	364
2024 Q1	$642K	Buy	+4,652	New	+$642K	0.06%	255